T2D Excellence Forum

Excellence Forum

Leaders in the field share expert insights and institutional best practices.
News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Q&As

Expert Q&A
Dr Tang
Expert Q&A
How Will the ADA Guidelines Impact GLP-1 RA, SGLT-2 Inhibitor Usage?
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024
Expert Q&A
Gulsen Ozen
Expert Q&A
Statin Use in Patients With RA to Reduce CVD, Type 2 Diabetes Risk
12/09/2023
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
12/09/2023
Expert Q&A
Robin Gal
Expert Q&A
Using a Telehealth Model in the Management of Patients With Diabetes
11/30/2023
Robin Gal, MSPH, CCRA; Grazia Aleppo, MD, FACE, FACP; Teresa McArthur, MS, RD, CDCES
In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...
11/30/2023